Skip to main content
PeerJ logoLink to PeerJ
. 2022 Oct 5;10:e14097. doi: 10.7717/peerj.14097

MicroRNA let-7f-5p regulates PI3K/AKT/COX2 signaling pathway in bacteria-induced pulmonary fibrosis via targeting of PIK3CA in forest musk deer

Wei Zhao 1, Jianguo Cheng 2,✉, Yan Luo 1,✉, Wenlong Fu 2, Lei Zhou 2, Xiang Wang 1, Yin Wang 1, Zexiao Yang 1, Xueping Yao 1, Meishen Ren 1, Zhijun Zhong 1, Xi Wu 1, Ziwei Ren 1, Yimeng Li 1
Editor: Rogerio Sotelo-Mundo
PMCID: PMC9547585  PMID: 36217380

Abstract

Background

Recent studies have characterized that microRNA (miRNA) is a suitable candidate for the study of bleomycin/LPS-induced pulmonary fibrosis, but the knowledge on miRNA in bacteria-induced pulmonary fibrosis (BIPF) is limited. Forest musk deer (Moschus berezovskii, FMD) is an important endangered species that has been seriously affected by BIPF. We sought to determine whether miRNA exist that modulates the pathogenesis of BIPF in FMD.

Methods

High-throughput sequencing and RT-qPCR were used to determine the differentially expressed miRNAs (DEmiRNAs) in the blood of BIPF FMD. The DEmiRNAs were further detected in the blood and lung of BIPF model rat by RT-qPCR, and the targeting relationship between candidate miRNA and its potential target gene was verified by dual-luciferase reporter activity assay. Furthermore, the function of the candidate miRNA was verified in the FMD lung fibroblast cells (FMD-C1).

Results

Here we found that five dead FMD were suffered from BIPF, and six circulating miRNAs (miR-30g, let-7f-5p, miR-27-3p, miR-25-3p, miR-9-5p and miR-652) were differentially expressed in the blood of the BIPF FMD. Of these, let-7f-5p showed reproducibly lower level in the blood and lung of the BIPF model rat, and the expression levels of PI3K/AKT/COX2 signaling pathway genes (PIK3CA, PDK1, Akt1, IKBKA, NF-κB1 and COX2) were increased in the lung of BIPF model rats, suggesting that there is a potential correlation between BIPF and the PI3K/AKT/COX2 signaling pathway. Notably, using bioinformatic prediction and experimental verification, we demonstrated that let-7f-5p is conserved across mammals, and the seed sequence of let-7f-5p displays perfect complementarity with the 3’ UTR of PIK3CA gene and the expression of the PIK3CA gene was regulated by let-7f-5p. In order to determine the regulatory relationship between let-7f-5p and the PI3K/AKT/COX2 signaling pathway in FMD, we successfully cultured FMD-C1, and found that let-7f-5p could act as a negative regulator for the PI3K/Akt/COX2 signaling pathway in FMD-C1. Collectively, this study not only provided a study strategy for non-invasive research in pulmonary disease in rare animals, but also laid a foundation for further research in BIPF.

Keywords: Bacteria-induced pulmonary fibrosis, Forest musk deer, Let-7f-5p, PIK3CA gene, PI3K/AKT/COX2 signaling pathway

Introduction

Forest musk deer (FMD) is listed as endangered by the International Union of the Conservation of Nature. The adult male FMD could secrete musk, which play an important economic value in traditional Asian medicine and international perfume industries. The population of captive FMD has been hampered by bacterial pneumonia, which accounts for 50% of all deaths. Specifically, pulmonary fibrosis has been presented in almost all of the bacterial pneumonia FMD (Zhang, Wang & Lin, 1997; Zhao et al., 2020). Pulmonary fibrosis is one of the respiratory refractory diseases affecting human and animal health (Williams, 2014), which is a progressive fatal disease accompanied by the inflammatory response, excessive proliferation of fibroblast cell, and deposition of extracellular matrix (ECM) (Williams, 2014; Hsu et al., 2017; Wang et al., 2021a). Many reasons can contribute to the shaping of pulmonary fibrosis, including virus infection, aberrant wound healing, irradiation, and environmental agents (Chioma & Drake, 2017). Of note, accumulating evidence suggests that infectious bacterial, such as Pseudomonas aeruginosa, Streptococcus pneumoniae, and Staphylococcus aureus, also play a role in pulmonary fibrosis (Chioma & Drake, 2017). The earliest evidence of bacterial involvement in pulmonary fibrosis showed that Mycobacteria can induce pulmonary lesions by the activator of T lymphocytes (Seggev, Goren & Kirkpatrick, 1984). By using the pulmonary fibrosis model, Knippenberg et al. (2015) uncover a novel mechanism that Streptococcus pneumoniae causes progression of established pulmonary fibrosis in mice through releasing pneumolysin. In addition, the correlation between lung microbiome and pulmonary fibrosis was analyzed by 454 pyrosequencing, and the results showed that the pulmonary fibrosis progression is associated with the presence of Streptococcus genera (Han et al., 2014). Currently, the mechanism of bleomycin/LPS-mediated pulmonary fibrosis has been widely studied in recent years, much less data is available in BIPF (Chioma & Drake, 2017).

MiRNAs are non-coding small RNAs that play vital roles in the posttranscriptional regulation of gene expression (Chen et al., 2008). In recent years, studies have shown that miRNAs have been widely used in the study of the pathogenic mechanisms of many diseases, including infectious diseases (Bhaskaran & Mohan, 2014). Most importantly, Chen et al. (2008) reported that a barrage of miRNAs are present in body fluids (blood, saliva, tears, urine, milk and seminal fluid), termed circulating miRNAs, which might play a role in information transfer from organs/tissue to the body fluid. Thus, the specific expression profiles of circulating miRNAs can reflect changes in expression in organs/tissue. Slota et al. (2019) study in Père David’s deer chronic wasting disease found that the expression profile of circulating miRNAs were changed in prion disease individual, of note, miR-148a-3p, miR-186-5p, and miR-30e−3p were proved to have a strong correlation with prion disease. The follow-up studies have characterized that circulating miRNAs are suitable candidates to serve as a study strategy for pulmonary fibrosis (Liu et al., 2021). Huang et al. (2012) reported that miR-125b-5p, miR-128, miR-30e, and miR-20b were significantly changed in lung tissue and in plasma of fibrosis mice. Chouri et al. (2018) demonstrated that circulating miR-483-5p could regulate the expression of fibrosis-related genes in fibroblast and endothelial cells by screening and functional study of miRNA in mice serum.

At present, the mechanism of bleomycin/LPS-mediated pulmonary fibrosis has been widely studied in recent years, but the pathogenesis of BIPF is limited (Liu et al., 2018; Chioma & Drake, 2017). Herein, we sought to determine whether miRNAs exist that modulates the pathogenesis of BIPF in FMD. Using high-throughput sequencing and experimental verification, we have confirmed that circulating let-7f-5p is differentially expressed in blood of BIPF FMD and rats compared to the healthy control. Furthermore, the role of let-7f-5p in regulating the PI3K/AKT/COX2 signaling pathway was validated in the lung of BIPF-infected rat and FMD-C1, which implied that let-7f-5p could regulate the PI3K/AKT/COX2 signaling pathway in BIPF. Collectively, our results uncover a novel role for let-7f-5p in BIPF, which provided promising knowledge for further BIPF researches.

Materials & Methods

FMD experiment

Sample collection

Blood samples were collected from five healthy (H1-H5; three male and two female, n = 5) and five dead (P1-P5; three male and two female, n = 5) FMD (Sichuan Institute of Musk Deer Breeding) and stored at −80 °C in the blood RNA Shield tube (Tianmo, Beijing, China). The sick FMD were looked after by us throughout the day. When the condition worsened, we monitored their breathing, heartbeat, pulse, and reflexes. With the disappearance of the above indicators, we determined that the FMD died, and performed an autopsy on the FMD, it was observed that the lungs were surrounded by peptone-like exudate. To meet the required standards of blood sample for testing, the cause of death of FMD was detected by pathogen detection and histopathological observation, molecular identification based on 16S rDNA sequences was conducted using general primers 27F and 1492R as previously described (Zhao et al., 2017). Besides, to examine the degree of fibrosis, the lung specimens were harvested and fixed with 4% paraformaldehyde solution for histological analysis with Masson’s trichrome and Picrosirius red staining. The animal study protocol was approved by the Ethics Committee of Sichuan Agricultural University (protocol code No. SYXK2019-187).

RNA extraction and RNA library construction

The RNA was extracted from six mL blood from each individual healthy (n = 5) and dead (n = 5) FMD using a Total RNA extraction kit (Tianmo, Beijing, China) following the manufacturer’s instructions. The statistical power of this experimental design, calculated in G*Power software (3.1.9.7, http://www.gpower.hhu.de/) (Kang, 2021) is 0.42. The integrity of RNA was assessed using electrophoresis with 1.0% denatured agarose gel and Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). The RNA concentration was determined by a NanoDrop ND1000 system (Thermo Fisher Scientific, Waltham, MA, USA). The RNA meeting the following requirements was used for library construction: (a) The total RNA concentration is greater than 200 ng/µL; (b) RNA integrity number ≥ 8; (c) 28S/18S ratio ≥ 1.8. The small RNA libraries were generated using NEBNext® Multiplex Small RNA Library Preparation kit (New England Biolabs, Ipswich, MA, USA) according to the manufacturer’s instructions. The RNA was reverse transcribed into cDNA immediately using Super Script II Reverse Transcriptase (Invitrogen, Waltham, MA, USA). Fragmented libraries were enriched by PCR amplification, and added with universal PCR primers and an index (X) primer. Prior to sequencing, the quality and quantity RNA libraries were evaluated by Agilent 2100 Bioanalyzer with Agilent High Sensitivity DNA Kit and Quant-iT PicoGreen dsDNA Assay Kit, respectively. Finally, qualified libraries were sequenced on Illumina NextSeq 500 sequencing platform producing 75-bp single end reads (>23 million for each sample) at Personal Biotechnology Co., Ltd (Shanghai, China).

RNA sequencing data analysis

After getting the raw data (5 healthy and 5 dead FMD blood samples), the ligated adapter sequences were removed by Cutadapt software (https://cutadapt.readthedocs.io/), the sequence data of low quality reads (average quality score <20; read lengths <18 and >32 nt) were discarded (Sun et al., 2019a). Next, the Rfam database (http://rfam.janelia.org/) was used to extract the reads of rRNAs, tRNAs, snRNAs, and snoRNAs. The rest of reads were aligned to the miRBase 21 databases (http://www.mirbase.org/), and achieved the conservative miRNA (each miRNA was allowed ≤ 2 base mismatches). The expression level of the known miRNA was quantified as Transcripts Per Million values. The DESeq2 package (http://www.bioconductor.org/packages/release/bioc/html/ DESeq2.html) was used to analyze DEmiRNAs with p < 0.05 and —log2fold change— >1. Subsequently, miRanda v3.3a (http://cbio.mskcc.org/microrna_data/manual.html) and TargetScan 7.2 (http://www.targetscan.org/vert_72/) were used to predict the target genes of DEmiRNAs. DEmiRNAs-target gene network was visualized using the Cytoscape software (ver. 3.6.1; http://www.cytoscape.org). Functions and metabolic pathways of these target genes were classified by the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways, and KEGG pathways were screened at p-value <0.05 and false discovery rate (FDR) <0.05.

RT-qPCR quantification of the DEmiRNAs in FMD blood

In this study, 1.5 µL of 20 pmol/µL synthetic C. elegans miRNA (cel-miR-39: 5′-UCACCGGGUGUAAAUCAGCUUG-3′) was added to the blood, which was used for sample-to-sample normalization (Kroh et al., 2010; Hromadnikova et al., 2017). Then, the total RNA of each individual healthy (n = 5) and dead (n = 4) (All the blood sample of a dead FMD (P4) was used to miRNA-seq) FMD blood was extracted using Total RNA extraction kit (Tianmo, Beijing, China) following the manufacturer’s instructions. The RNA was reverse transcribed into miRNA cDNA immediately using miRcute Plus miRNA First-Strand cDNA synthesis Kit (TianGen, Beijing, China). The DEmiRNAs were detected using miRcute Plus miRNA qPCR Kit (SYBR Green) (TianGen, Beijing, China). The PCR conditions were as follows: initial denaturation at 95 °C for 15 min, 5 thermal cycles (94 °C for 20 s, 64 °C for 30 s, 72 °C for 34 s) to enrichment of target miRNAs, 45 cycles of 94 °C for 20 s and 60 °C for 34 s. The DEmiRNAs forward primers were designed based on mature miRNA sequences and reverse primers were provided by the miRcute Plus miRNA qPCR Kit (SYBR Green) (TianGen, Beijing, China). The target miRNAs in the blood were normalized using the synthetic C. elegans cel-miR-39 (Kroh et al., 2010). The sequences of the DEmiRNAs primers used are listed in Table S1. The relative DEmiRNAs expression levels were calculated using the 2−ΔΔCT method.

Rat experiment

Construction of BIPF model and sample collection

In order to establish BIPF model, we carried out a pilot study and found that the pathogenic bacteria isolated from FMD lung, including Klebsiella pneumoniae strain DJY-1, Pseudomonas aeruginosa strain YW1 and Streptococcus equinus strain FMD1, which could cause bacterial pneumonia in rodents (Zhao et al., 2021). A total of 20 adult female Wistar rats (8-week-old; specific-pathogen-free) (Chengdu Dossy Experimental Animals Co, Ltd, Chengdu, 610000, China) were randomly divided into four groups, which received sterile physiologic saline as control group (CG group, n = 5), Klebsiella pneumoniae (KG group, n = 5), Pseudomonas aeruginosa (PG group, n = 5) and Streptococcus equinus (SG group, n = 5) by nasal drip under anesthesia as described in Chen et al. (2017). For group KG, PG and SG, the three pathogens were administered at a dose of 108∼109 CFU per rat. In order to prevent cross-contamination of pathogens, each group rats were housed in a separate cage with enough distance. The rats had free access to food and water ad libitum with a 12 h light/dark cycle. On day 21, the rats were weighed and sacrificed after anesthesia, and the blood was collected into blood RNA Shield tube (Tianmo, Beijing, China). The lung samples were weighed and collected, and then one part of the lung tissue was collected into RNALater™ RNA Stabilization Reagent (Beyotime, Shanghai, China). The blood and lung specimens were stored at liquid nitrogen until total RNA extraction. Immediately afterward, the other part was fixed with 4% paraformaldehyde solution and stained with hematoxylin-eosin (HE), masson’s trichrome and picrosirius red staining.

RT-qPCR quantification of the DEmiRNAs in rat blood and lung

The method of DEmiRNAs in rat blood and lung determination was the same as above. There is a slight difference in the lung miRNA detection that the target miRNAs in the lung were normalized using U6 snRNA (Wang et al., 2017). The sequences of the DEmiRNAs primers used are listed in Table S1. The relative DEmiRNAs expression levels were calculated using the 2−ΔΔCT method.

RT-qPCR analysis of the BIPF-related genes in rat lung

We evaluate the expression level of pulmonary fibrosis-related genes, including transforming growth factor-β1 (TGF-β1), tumor necrosis factor- α (TNF-α), and PI3K/AKT/COX2 signaling pathway genes: phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha (PIK3CA), phosphoinositide-dependent protein kinase 1 (PDK1), serine/threonine kinase 1 (Akt1), inhibitor of nuclear factor kappa-B kinase subunit alpha (IKBKA), nuclear factor kappa B subunit 1 (NF-κB1) and cyclooxygenase-2 (COX2), in the rat lung tissue using RT-qPCR analysis. The total RNA was extracted from the rat lung using Total RNA extraction kit (Tianmo, Beijing, China), and reversed transcribed using HiScript III 1st Strand cDNA Synthesis Kit (+gDNA wiper) (Vazyme Biotech Co., Ltd, Nanjing, China). The β-actin was used as reference gene. The sequences of the gene primers used are listed in Table S2. The relative gene expression level was calculated using the 2−ΔΔCT method.

Western blot analysis

Total protein was extracted from rat lung tissue using Tissue or Cell Total Protein Extraction Kit (Sangon Biotech Co., Ltd, Shanghai, China) and protein concentration was determined by bicinchonininc acid (BCA) Protein Assay Kit (TianGen, Beijing, China). The PI3K/AKT/COX2 signaling pathway related proteins (PI3K, AKT1, and COX2) were analyzed by western blot. Equal amounts of 50 µg total proteins were separated on 10% SDS-PAGE gels and then transferred onto polyvinylidene fluoride (PVDF) blotting membranes. After being blocked with 5% bovine serum albumin (BSA) in phosphate buffer, the membranes were incubated with primary antibodies at 4 °C for the night. The primary antibodies used were PIK3CA rabbit polyclonal antibody (diluted 1:2,000), phospho-AKT1 (Ser473) rabbit polyclonal antibody (diluted 1:800), anti-COX2 antibody (diluted 1:1,000), and β-Actin rabbit monoclonal antibody (diluted 1:1,000). Following incubation with goat anti-rabbit secondary antibody (diluted 1:1,000) for 2 h at room temperature, the protein bands were visualized using an enhanced chemiluminescence detection system. The β-actin was used as an internal control for assessing equal loading of total protein among wells. In this study, the primary and secondary antibodies were purchased from Beyotime biological technology Co., Ltd (China) and Boster biological technology Co., Ltd (America).

Generation of Luciferase Constructs and Luciferase Assays

The PIK3CA was predicted as target gene of let-7f-5p. For experimental validation of the PIK3CA 3′ UTR (untranslated region) as a target of let-7f-5p, the luciferase reporter plasmid was constructed, and a 200-bp fragment of the PIK3CA mRNA 3′ UTR containing the predicted let-7f-5p binding site (seed sequence) (PIK3CA mRNA 3′ UTR-WT) and its mutant sequence (PIK3CA mRNA 3′ UTR-MUT) were synthesized by Sangon and cloned into psiCHECKTM-2 vector (Sangon Biotech Co., Ltd., Shanghai, China) based on the Xho I and Not I restriction sites. The recombinant plasmids were confirmed by double digest and PCR amplification, the primers used are listed in Table S3. The FAM-labeled let-7f-5p mimics (5′-UGAGGUAGUAGAUUGUGUAGU-3′), let-7f-5p inhibitor (5′-ACUAUACAAUCUACUAC CUCA-3′) and mimics NC (5′-UUGUACUACACAAAAGUACUG-3′) were synthesized by Sangon. For transient transfections, the optimum concentration of let-7f-5p mimics, let-7f-5p inhibitor and mimics NC were carried out in HEK293T cells with the luciferase reporter constructs using Lipo8000™ Transfection Reagent (Beyotime Biotechnology, Co., Ltd., Shanghai, China). After 24 h of transfection, HEK293T cells were lysed by TransDetect® Double-Luciferase Reporter Assay Kit (TransGen Biotech Co., Ltd. Beijing, China) and the luciferase activity was measured by a Full wavelength scanning, multifunction reading instrument (Thermofisher, USA). The Renilla luciferase activities were normalized by that of firefly luciferase.

The correlation analysis between let-7f-5p and PI3K/AKT/COX2 signaling pathway in FMD fibroblast cells

Package of the recombinant adeno-associated virus (rAAV)

The pAAV-CMV-eGFP and helper plasmids were obtained from Prof Zhao, Huazhong Agricultural University, China (Huang et al., 2021). The FMD pri-let-7f-5p sequence (SPDX01004329: 114203-114718) was cloned into pAAV-CMV-eGFP plasmids based on the Hind restriction sites and homologous arm. The recombinant plasmids (rpAAV-pri-let-7f-5p) were confirmed by double digest and PCR amplification. Primers were designed based on the pAAV-CMV-eGFP sequence information (F: TGCTGCCCGACAACCA; R: CCCTTGCTCCATACC AC). Then, a packaging approach, which have been previously reported (Huang et al., 2021), was used to produce the rAAV, and the AAV was set as the blank control. Subsequently, the rAAV and AAV copy number was assessed by RT-qPCR and transduction assay according to the methods of Meng, Zhang & Zhang (2013). Finally, we successfully packaged the rAAV virus, which can be applied for let-7f-5p overexpressing in FMD-C1 cells (Fig. S1).

Effects of let-7f-5p on PI3K/AKT/COX2 signaling pathways

To provide further evidence that the PI3K/AKT/COX2 signaling pathway was regulated by let-7f-5p in FMD lung, we successfully isolated and cultured primary FMD-C1 cell, a detailed procedure of the methods of cell separation can be found in a previous study (Liu et al., 2012). FMD-C1 cells were transfected with let-7f-5p mimics and mimics NC using Lipo8000™ Transfection Reagent. Subsequently, FMD-C1 cells were infected with rAAVs and AAVs at a multiplicity of infection of 200 and incubated at 37 °C for 8 days. Finally, the expression level of PI3K/AKT/COX2 signaling pathway genes (PIK3CA, PDK1, Akt1, IKBKA, NF-κB1 and COX2) were detected by RT-qPCR. The total RNA was extracted from the rat lung and FMD-C1 using Total RNA extraction kit (Tianmo, Beijing, China), which was reversed transcribed using HiScript III 1st Strand cDNA Synthesis Kit (+gDNA wiper) (Vazyme Biotech Co., Ltd, Nanjing, China), the β-actin was used as reference gene. The sequences of the gene primers used in this study are listed in Table S2. The relative gene expression level was calculated using the 2−ΔΔCT method.

Statistical analysis

Statistical analyses were performed using GraphPad Prism 7.00 software. Data have been expressed as means ± Standard Error of Mean. Two-tailed student’s t test was performed to test for differences between the two groups, *p-value <0.05; **p-value <0.01.

Results

Pathogen identification and pathology analysis

The five FMD individuals died of bacterial pneumonia, and a pathogen was isolated from the lung of each of the dead FMD, namely Pseudomonas aeruginosa strain YW1 (Genbank NO. MN027911.1), Pseudomonas aeruginosa strain FMDP002 (Genbank NO. MN904450.1), Klebsiella pneumoniae strain DJY-1 (Genbank NO. OK036428), Streptococcus equinus strain FMD1 (Genbank NO. MK652875.1) and Trueperella pyogenes strain ZW1 (Genbank NO. MN027909.1), respectively (Fig. S2). In the five FMD lungs, histopathological examination showed some similar pathological changes in each individual, mainly including the normal structure of alveolus was lost, fibrous tissue was increased, and the lung interstitium was filled with a large number of fibroblast cells, neutrophils and lymphocytes. Picrosirius red and Masson’s trichrome staining showed increased fibrin and collagen in lung tissue of FMD (Fig. 1), implying that the five dead FMD were suffered from BIPF.

Figure 1. Histological analysis of five dead forest musk deer lung tissue (400×).

Figure 1

The black, red and green arrow indicates the lymphocytes, fibrin and collagen, respectively; P1-P5 indicates the five dead forest musk deer, respectively.

Construction of BIPF model

In the rat model, the ratio of the wet lung to body weight was calculated at 21 days post infection. Compared with the control group CG, the test group KG and PG exhibited significantly higher wet lung to body weight ratio (p < 0.01), but no significant change in test group SG (Fig. 2A). The results of the histological analysis are as follows: in the CG group, the normal structure of the rat lung was complete and clear, and no hyperplasia or thickening of connective tissue was found. The bronchial structure at all levels was complete and clear, and the alveolar epithelial cells were normal in shape without obvious degeneration, necrosis or exfoliation. Additionally, no obvious inflammatory cell infiltration and fibrous hyperplasia were observed in the interstitium. In three test group rats, the alveolar wall was collapsed in the rat lung tissue. The collagen fibers were proliferated in the lung interstitium. Besides, a large amount of fibroblast cells, inflammatory cells (mainly neutrophils and lymphocytes) were infiltrated in the lung interstitium (Fig. 2B). Picrosirius red and Masson’s trichrome staining showed that the lung tissues of three test groups (KG, PG and SG) exhibited severe fibrin and collagen secretion compared with that of the control group (Figs. 2B and 2C). Of note, the expression levels of TGF-β1 and TNF-α were both upregulated in the lung of test group rats compared with that of the control group (Fig. 2D). These results indicate that the lung of rat in three test groups had developed fibrosis.

Figure 2. Construction of rat model of bacteria-induced pulmonary fibrosis based forest musk deer pathogens.

Figure 2

(A) The ratio of wet lung to body weight of four group rats. (B) Histological analysis of rat lung tissues with HE, Masson’s trichrome and Picrosirius red staining (400×). (C) The quantification of Masson’s trichrome and Picrosirius red staining. (D) The expression level of TGF-β1 and TNF- α in the lung of rat (p-values were calculated using Student’s t test. * p-value < 0.05, ** p-value < 0.01). The black, red and green arrow indicates the lymphocytes, fibrin and collagen, respectively. The “CG”, “KG”, “PG”, and “SG” indicates the control group , Klebsiella pneumoniae group, Pseudomonas aeruginosa group and Streptococcus equinus group, respectively.

Analysis of BIPF related miRNAs

As there is no available miRNA annotation information in miRBase21 for FMD, the known miRNAs were identified by blast searches against all animal reference sequences in miRBase21. Between 25 and 42 million raw reads were obtained for each sample (Table S4). After being trimmed, a total of 313 million clean reads (>18 nt) were obtained. Among these clean reads, small RNA with the length of 18–24 nt was most abundant in FMD blood samples. The miRNAs profiles of each blood samples were identified based on the miRBase21 database after the annotated and unconcerned reads were removed such as rRNA, tRNA, snRNA and snoRNA. A total of 10,088 known miRNAs were identified from 10 blood samples. Among these known miRNAs in the study, nine DEmiRNAs, namely, miR-30g, let-7f-5p, miR-25-3p, miR-27d-3p, miR-451-3p, miR-142-5p, miR-652, miR-9-5p and miR-206-3p, satisfied the screening criteria of p < 0.05, —log2fold change—>1 between the healthy and dead group FMD. Expression of miR-451-3p, miR-142-5p, miR-652, miR-9-5p and miR-206-3p expression were upregulated in the dead group. Four miRNAs, miR-30g, let-7f-5p, miR-25-3p and miR-27d-3p, were downregulated in the dead group (Table 1). We selected the nine DEmiRNAs to determine their expression patterns using RT-qPCR detection in FMD and rat blood. In the FMD blood, the results of RT-qPCR showed that the trend of 5 DEmiRNAs (miR-30g, let-7f-5p, miR-27-3p, miR-25-3p and miR-652) expression was consistent with the high-throughput sequencing data (Fig. 3A), indicating significant differences in the 6 DEmiRNAs expression between the healthy and dead FMD. In rat model, of the nine miRNAs tested in FMD blood, the let-7f-5p and miR-27d-3p expression level were reduced in the blood of test rat, and the level of miR-652 increased in the three test groups compared with the control group (Fig. 3B). The same changes of let-7f-5p and miR-652 were also observed in the lung of BIPF rats (Fig. 3C).

Table 1. The information of differentially expressed miRNAs between healthy and bacteria-induced pulmonary fibrosis forest musk deer.

MiRNAs Mature sequence p-value log2 fold change Regulation
miR-30g UGUAAACAUCCUUCACUCUCAGC 0.020657204 −3.834803637 Down Regulation
let-7f-5p UGAGGUAGUAGAUUGUGUAGU 0.045518112 −4.008303155 Down Regulation
miR-27d-3p UUCACAGUGGCUAAGUUCGG 0.040976811 −12.20641173 Down Regulation
miR-25-3p CAUUGCACUUGUCUCGGC 0.01127513 −3.87762947 Down Regulation
miR-142-5p CCCAUAAAGUAGAAAGCACUAC 0.043664864 2.442527514 Up Regulation
miR-451-3p AUGGUAACGGUUCUCUUGCUG 0.02039289 3.609186008 Up Regulation
miR-652 UGAAUGGCGCCACUAGGGUUGUG 0.04590716 a Up Regulation
miR-9-5p UCUUUGGUUAUCUAGCUGUGUG 0.043801272 a Up Regulation
miR-206 UGGAAUGUAAGGAAGUGUGUGG 0.000474216 a Up Regulation

Notes.

a

The standardized mean expression of miRNAs in the healthy group is zero by high-throughput sequencing.

Figure 3. Screening of key miRNAs involved in bacteria-induced pulmonary pulmonary fibrosis.

Figure 3

(A) RT-qPCR analysis of differentially expressed miRNAs in blood between healthy and bacteria-induced pulmonary fibrosis forest musk deer (The “H” and “P” indicates the healthy and dead group, respectively). (B) RT-qPCR analysis of differential expression miRNAs in blood between control group and test group rats. (C) RT-qPCR analysis of differential expression miRNAs in lung between control group and test group rats (p-values were calculated using Student’s t test. *p -values < 0.05, ** p-values < 0.01). The “CG”, “KG”, “PG”, and “SG” indicates the control group, Klebsiella pneumoniae group, Pseudomonas aeruginosa group and Streptococcus equinus group, respectively.

Analysis of BIPF related pathway

Among the KEGG term, twelve KEGG pathways significantly enriched for target genes of the DEmiRNAs (p < 0.05; FDR < 0.05) (Table 2, Fig. 4A) based on KEGG analysis. Importantly, the pathway of ECM-receptor interaction and focal adhesion may be of particular importance in this study since these two pathways often associated with lung-related diseases, for example pulmonary fibrosis (Tian et al., 2019). As aforementioned in the target gene analysis, a total of 21 and 39 target genes of the let-7f-5p and miR-652 were involved in ECM-receptor interaction and focal adhesion pathways, respectively (Fig. 4B). It is worth noting that the whole and seed sequences of let-7f-5p are highly conserved across species, and the seed sequence is complementary with the binding site on the PIK3CA mRNA (Fig. 4C), suggesting that the let-7f-5p may participate in post-transcriptional regulation of PIK3CA gene. The luciferase reporter plasmid was constructed for experimental validation of the relationship between let-7f-5p and PIK3CA (Fig. S3). The luciferase reporting assay confirmed the direct target relationship between let-7f-5p and the PIK3CA gene (Fig. 4D). In addition, the PI3K/AKT/COX2 signaling pathway genes (PIK3CA, PDK1, Akt1, IKBKA, NF- κB1 and COX2) were examined in rat model. Compared to control group, three test groups of rats exhibited increased mRNA expression level of PIK3CA, PDK1, IKBKA, NF-κB1 and COX2 genes with significant difference (p < 0.05) (Fig. 5A). In addition, the mRNA expression level of Akt1 gene exhibited a trend of increase in three test group rats, and significantly increased in PG rats (p < 0.05) (Fig. 5A). Besides, compared with the control group, three test groups exhibited significantly higher protein expression levels of PI3K, AKT1, and COX2 (Fig. 5B). The high level of the PI3K/AKT/COX2 signaling pathway mRNA and protein expression found in three test group rats, suggesting that there is a potential correlation between BIPF and the PI3K/AKT/COX2 signaling pathway.

Table 2. KEGG enrichment analysis of target genes of nine differentially expressed miRNAs.

Rank KEGG pathways Target genes p-value FDRa
1 Olfactory transduction 16 2.00445E−08 6.79508E−06
2 Axon guidance 88 7.72678E−06 0.001205408
3 ABC transporters 34 1.06673E−05 0.001205408
4 ECM-receptor interaction 44 1.71932E−05 0.001457125
5 Fatty acid biosynthesis 6 3.11572E−05 0.002112458
6 Bile secretion 38 0.000188414 0.010645395
7 Focal adhesion 91 0.000248674 0.012042906
8 Aminoacyl-tRNA biosynthesis 42 0.000420139 0.017283098
9 Dilated cardiomyopathy 51 0.000458843 0.017283098
10 Arrhythmogenic right ventricular cardiomyopathy 42 0.000566274 0.0191967
11 Hypertrophic cardiomyopathy 46 0.000710711 0.021902822
12 Endocrine and other factor-regulated calcium reabsorption 22 0.001043918 0.02949068

Notes.

a

FDR indicates the false discovery rate.

Figure 4. Analysis of the relationship between let-7f-5p and PIK3CA gene.

Figure 4

(A) KEGG functional enrichment analysis of the target genes of differentially expressed miRNAs. (B) Predicted target genes for let-7f-5p and miR-652 in the ECM-receptor interaction and focal adhesion pathways, respectively. (C) A mature let-7f-5p sequence is conserved among different species, and sequence alignment between let-7f-5p and PIK3CA 3′ UTR of forest musk deer, rat, cow, rabbit and human is observed. The sequences in the red frame are seed sequences of let-7f-5p . The “Mbe”, “Chi”, “Hsa”, “Bta”, “Cpo”, “Ocu” and “Rno” indicates the “Moschus berezovskii”, “Capra hircus”, “Homo sapiens”, “Bos taurus”, “Cavia porcellus”, “Oryctolagus cuniculus” and “Rattus norvegicus”, respectively . (D) let-7f-5p negatively regulates PIK3CA gene. PIK3CA mRNA 3′ UTR wild type (PIK3CA-WT) and PIK3CA mRNA 3′UTR mutant type (PIK3CA -MUT) reporter plasmids were cotransfected with the let-7f-5p mimics and let-7f-5p inhibitor in HEK293T cells, and the mimics NC group was also set. The results were expressed as relative luciferase activity (Renilla LUC/Firefly LUC). ( p-values were calculated using Student’s t test. * p-values < 0.05); “NC” indicates the negative control.

Figure 5. The expression level of PI3K/AKT/COX2 signaling pathway genes in bacteria-induced pulmonary fibrosis rat lung.

Figure 5

(A) RT-qPCR analyses of PI3K/AKT/COX2 signaling pathway genes. (B) Western blot for quantification of PI3K/AKT/COX2 signaling pathway related proteins in rat lungs, with β-actin as internal control (p-values were calculated using Student’s t test. *p-values < 0.05, **p-values < 0.01). The “CG”, “KG”, “PG”, and “SG” indicates the control group, Klebsiella pneumoniae group, Pseudomonas aeruginosa group and Streptococcus equinus group, respectively.

The role of let-7f-5p in the PI3K/AKT/COX2 signaling pathway

Overall, we hypothesized that the let-7f-5p may participate in the regulation of the PI3K/AKT/COX2 signaling pathway in BIPF FMD. After 24 h of transfection, the PIK3CA, PDK1, Akt1, IKBKA, NF- κB1 and COX2 expression decreased in let-7f-5p mimics group compared with let-7f-5p mimics NC group (Fig. 6). In addition, the PI3K/AKT/COX2 signaling pathway genes were decreased in rAAV infection FMD-C1 (Fig. 6). These results supported the hypothesis that the let-7f-5p could regulate the PI3K/AKT/COX2 signaling pathway in the FMD lung.

Figure 6. Effect of let-7f-5p on the PI3K/AKT/COX2 signaling pathway in forest musk deer fibroblast cells.

Figure 6

“NC” indicates the negative control, “AAV” indicates the adeno- associated virus, “rAAV” indicates the recombinant adeno-associated virus, the p-values were calculated using Student’s t test. *p-value < 0.05, ** p-value < 0.01.

Discussion

Pulmonary fibrosis is the final stage of many lung diseases in humans, which have also been described in dogs, cats, horses and FMD (Zhang, Wang & Lin, 1997; Zhao et al., 2020; Williams, 2014; Marenzoni et al., 2011). In this study, five FMD were found suffering from BIPF. FMD is an endangered and protected animal in China, just like other protected animals, it is forbidden to conduct animal regression experiments on FMD. However, it is not conducive to the study of BIPF of FMD without healthy control. Therefore, in this study, BIPF model in rat was established by FMD origin pathogens, including Klebsiella pneumoniae, Pseudomonas aeruginosa and Streptococcus equinus. These pathogens are isolated from the FMD lung and have been shown to cause the death of mice (Zhao et al., 2020; Zhao et al., 2021). HE, Picrosirius red and Masson’s trichrome staining showed increased inflammatory cells, fibrin and collagen in the lung of test group rats, demonstrating that these lung tissues are fibrosis. Hsu et al. (2017) have also measured the morphology of pulmonary fibrosis using HE, Picrosirius red and Masson’s trichrome staining. Meanwhile, the level of TGF-β1 and TNF-α were upregulated in the lung of the test group rats. Similar results have been reported in bleomycin/LPS-induced pulmonary fibrosis model (Hu et al., 2020; Elliot et al., 2019). Reportedly, TGF-β1 and TNF-α are important cytokines in mediating pulmonary fibrosis and have been demonstrated in many studies (Li et al., 2018). TGF- β1 promotes the growth of fibroblast cells and the accumulation of ECM, mainly collagen and fibronectin, and also could inhibit the degradation of ECM (Chioma & Drake, 2017). TNF-α has been widely accepted as an important inflammatory cytokine, and has also been reported to exacerbate the inflammatory response and promote TGF-β1 secretion in lung fibroblast cells (Wang et al., 2021b). Collectively, these results demonstrated that the origin of FMD pathogen could cause BIPF in rat. Establishment of the rat model of BIPF may lay a foundation for the study of pathogenesis of BIPF in FMD.

In this study, nine DEmiRNAs were found in the blood between the healthy and dead group FMD. It was reported that circulating miRNA may provide information about the disease status of organ/tissue and contain fingerprints for a range of many diseases (Chen et al., 2008), and have been applied to the diagnosis and mechanism research of pulmonary disease in human (Liu et al., 2021). Besides, miRNAs are conserved between species that we can use the same sequence between different animals, and its function could be verified in animal model (Lin, Chang & Ying, 2006). Thus, we used RT-qPCR to analyze the transcript level of the nine FMD blood DEmiRNA in blood and lung of BIPF model rat, and found that let-7f-5p and miR-652 were differentially expressed simultaneously in the rat blood and lung, suggesting that the let-7f-5p and miR-652 might be new candidates for the mechanism study of BIPF. Previous researches in miR-652 analysis have tended to focus on tumor proliferation and metastasis (Sun et al., 2018). The let-7 family miRNAs have previously been shown to participate in regulation of the pulmonary fibrosis. For example, Li et al. (2018) reported that let-7 family miRNA was proved to be an inhibitor that could downregulate estrogen receptor which plays a pivotal role in male-predominant pulmonary fibrosis. Also, Zhu et al. (2011) reported that let-7 plays a significant regulatory role in modulating glucose metabolism via negatively regulating the activity of the insulin-PI3K-mTOR signaling pathway. At the same time, research suggests that the change in glucose metabolism is an important pathogenic process of pulmonary fibrosis, and the effects were linked to the TGF-β secretion, ECM synthesis, collagen production, glucose transporter, inflammatory response, and immune response (Selvarajah et al., 2021; Yin et al., 2021; Gopu et al., 2020). These studies reinforce our notion that the let-7 family and PI3K may play important roles in the pulmonary fibrosis. Let-7f-5p, a member of the let-7 family, has been reported to remit pulmonary fibrosis through regulating cellular reactive oxygen species, mitochondrial DNA damage and cell apoptosis (Sun et al., 2019b). In the bleomycin-induced lung fibrosis model, Xie et al. (2011) reported that the potential target genes of let-7f may contribute to the complex transcriptional program of pulmonary fibrosis. Herein, we continuously select let-7f-5p to explore the underlying molecular mechanism of BIPF. To the best of our knowledge, this is the first demonstration of circulating miRNA change in any animal suffering from BIPF.

We know that miRNA play important roles in the regulation of target gene expression, which are often involved in some important pathway. In this study, the pathway-enriched analysis indicated that the target genes of the DEmiRNAs were highly associated with functions in the ECM-receptor interaction and focal adhesion pathways. In the pulmonary fibrosis patients, proteomic analysis of lung tissue showed that the altered proteins mainly belonged to ECM-receptor interaction and focal adhesion pathways (Tian et al., 2019). The abnormal ECM receptor interaction and focal adhesion pathways could lead to the accumulation of ECM, which has been identified as a major driving force for the development and persistence of fibrosis diseases (Liu et al., 2021). In addition, the target gene of let-7f-5p, including PIK3CA gene, was determined to be key gene that was reported to play an important role in the focal adhesion pathway (Margaria et al., 2022). It is worth noting that the PIK3CA gene is a key component in the PI3K/Akt pathway, which plays a critical role in the development pulmonary fibrosis (Hsu et al., 2017). With the in depth study of the PI3K/Akt pathway, studies reported that the activation of some factors, such as mammalian target of rapamycin, vascular endothelial growth factor and reactive oxygen species and COX2 in the downstream of the PI3K/AKT signaling pathway can participate in pulmonary fibrosis (Laddha & Kulkarni, 2019; Wu et al., 2018b). In the BIPF model, we found that the FMD pathogen promotes PI3K/AKT/COX2 signaling pathway related genes mRNA expression in rat lung. Recently, several studies have revealed that COX2 was highly induced by many different pathogens involved in pulmonary fibrosis, and COX2 can take part in the pathological process of alveolar inflammation and pulmonary fibrosis by inducing prostaglandin synthesis and microvascular hyperplasia (Wu et al., 2018b; Li, 2009). In pulmonary fibrosis model, Moore et al. (2000) found that compared with control mice, the expression level of COX2 was increased in the blood and lung of mice at 14 and 21 d after treated with bleomycin. Our results suggest that the PI3K/AKT/COX2 signaling pathway may contribute importantly to the pathogenesis of BIPF.

Taken together, we hypothesized that let-7f-5p is a key regulator of BIPF in FMD via targeting of the PI3K/AKT/COX2 signaling pathway. Therefore, we further demonstrated the targeting relationship between let-7f-5p and PIK3CA using bioinformatics analysis and experimental verification in HEK293T and FMD-C1 cells. This is consistent with previous research (Gilles & Slack, 2018), which showed that both let-7f-5p and its seed sequence were conserved between different species. In addition, we successfully isolated fibroblast cells from the lung of FMD, this is the first reported of fibroblast cells from FMD. As a key cell type driving the fibrogenic process, fibroblast cells can trigger pulmonary fibrosis directly through abnormal proliferating and transforming, and promote the secretion of ECM, cytokine and inflammatory cell. Moreover, various fields of pulmonary fibrosis researches have retained in relation to fibroblast cells (Wu, Tang & Kapoor, 2021). Notably, we found that let-7f-5p is a negative regulator for the PI3K/AKT/COX2 signaling pathway in FMD-C1, confirming our hypothesis that let-7f-5p could regulate PI3K/AKT/COX2 signaling pathway in BIPF through suppression of PIK3CA expression (Fig. 7). It is worth noting that the activation of PI3K is directly contribute to collagen- and fibro-proliferative has been confirmed repeatedly in many laboratories. Hsu et al. (2017) reported that many PI3K inhibitors have been developed for the treatment of pulmonary fibrosis. Thus, as a PI3K inhibitor, let-7f-5p may be a potential therapeutic molecule for BIPF.

Figure 7. Model of the let-7f-5p regulates the PI3K/AKT/COX2 signaling pathway in forest musk deer lung fibroblast cell.

Figure 7

Conclusions

In conclusion, we successfully identified let-7f-5p related to BIPF in FMD by combining the analysis of circulating miRNA, establishment of BIPF rat model and culture of FMD lung fibroblast cells. Of note, let-7f-5p could regulate the PI3K/AKT/COX2 signaling pathway in BIPF through suppression of PIK3CA expression. In this article, we believe that our study particularly strengthens the design for the non-invasive research in pulmonary disease in rare animals, and also provides further insights into the molecular mechanisms of BIPF.

Supplemental Information

Supplemental Information 1. Supplemental Information.

Table S1: RT-qPCR primers used for the verification of miRNAs; Table S2: RT-qPCR primers used for the verification of mRNAs; Table S3: Information of PCR primers for recombinant double luciferase reporter plasmids; Table S4: Overview of small RNA sequencing data in this study; Figure S1: Package of the recombinant adeno-associated virus; Figure S2: Isolation and identification of pathogens in forest musk deer lung; Figure S3: Verification of recombinant luciferase reporter plasmid.

DOI: 10.7717/peerj.14097/supp-1
Data S1. Raw data.
DOI: 10.7717/peerj.14097/supp-2
Supplemental Information 3. Original_Images for Blots/Gels.
DOI: 10.7717/peerj.14097/supp-3
Supplemental Information 4. Author Check.
DOI: 10.7717/peerj.14097/supp-4
Supplemental Information 5. Explanation of miRNA-seq raw data.
DOI: 10.7717/peerj.14097/supp-5

Acknowledgments

The authors are grateful to Personalbio Bioinformatics Technology, Co., Ltd. (Shanghai, China) for their skillful support in small RNAs sequencing.

Funding Statement

This research was funded by the Science and Technology Achievements Transfer Project in Sichuan province, grant number 2020JDZH0024 and 2022JDZH0026. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Contributor Information

Jianguo Cheng, Email: 447933018@qq.com.

Yan Luo, Email: Lycjg@163.com.

Additional Information and Declarations

Competing Interests

The authors declare there are no competing interests.

Author Contributions

Wei Zhao conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, authored or reviewed drafts of the article, writing—review and editing, and approved the final draft.

Jianguo Cheng conceived and designed the experiments, performed the experiments, authored or reviewed drafts of the article, and approved the final draft.

Yan Luo conceived and designed the experiments, performed the experiments, authored or reviewed drafts of the article, writing—review and editing, and approved the final draft.

Wenlong Fu performed the experiments, authored or reviewed drafts of the article, and approved the final draft.

Lei Zhou performed the experiments, authored or reviewed drafts of the article, and approved the final draft.

Xiang Wang performed the experiments, prepared figures and/or tables, authored or reviewed drafts of the article, and approved the final draft.

Yin Wang conceived and designed the experiments, analyzed the data, prepared figures and/or tables, and approved the final draft.

Zexiao Yang conceived and designed the experiments, analyzed the data, prepared figures and/or tables, and approved the final draft.

Xueping Yao conceived and designed the experiments, analyzed the data, prepared figures and/or tables, and approved the final draft.

Meishen Ren analyzed the data, prepared figures and/or tables, and approved the final draft.

Zhijun Zhong analyzed the data, prepared figures and/or tables, and approved the final draft.

Xi Wu performed the experiments, prepared figures and/or tables, and approved the final draft.

Ziwei Ren performed the experiments, prepared figures and/or tables, and approved the final draft.

Yimeng Li performed the experiments, prepared figures and/or tables, and approved the final draft.

Animal Ethics

The following information was supplied relating to ethical approvals (i.e., approving body and any reference numbers):

The animal study protocol was approved by the Ethics Committee of Sichuan Agricultural University (SYXK2019-187).

Data Availability

The following information was supplied regarding data availability:

The miRNA-sequencing raw data of forest musk deer is available at NCBI Sequence Read Archive: SRX9254510–SRX9254519.

References

  • Bhaskaran & Mohan (2014).Bhaskaran M, Mohan M. MicroRNAs: history, biogenesis, and their evolving role in animal development and disease. Veterinary Pathology. 2014;51:759–774. doi: 10.1177/0300985813502820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Chen et al. (2017).Chen HY, Pang FS, Chen JB, Xian ML, Yang YT, Hu Q, Qin Y. Anesthesia effects of chloral hydrate and pentobarbital sodium on postoperative fatigue syndrome in rats. Guangdong Medical Journal. 2017;38:1805–1808. doi: 10.13820/j.cnki.gdyx.20170607.004. [DOI] [Google Scholar]
  • Chen et al. (2008).Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Zhang Y, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Wang J, Zen K, Zhang J, Zhang CY. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Research. 2008;18:997–1006. doi: 10.1038/cr.2008.282. [DOI] [PubMed] [Google Scholar]
  • Chioma & Drake (2017).Chioma OS, Drake WP. Role of microbial agents in pulmonary fibrosis. The Yale journal of biology and medicine. 2017;90:219–227. [PMC free article] [PubMed] [Google Scholar]
  • Chouri et al. (2018).Chouri E, Servaas NH, Bekker CPJ, Affandi AJ, Cossu M, Hillen MR, Angiolilli C, Mertens JS, Van den Hoogen LL, Silva-Cardoso S, Van der Kroef M, Vazirpanah N, Wichers CGK, Carvalheiro T, Blokland SLM, Giovannone B, Porretti L, Marut W, Vigone B, Van Roon JAG, Beretta L, Rossato M, Radstake TRDJ. Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis. Journal of Autoimmunity. 2018;89:162–170. doi: 10.1016/j.jaut.2017.12.015. [DOI] [PubMed] [Google Scholar]
  • Elliot et al. (2019).Elliot S, Periera-Simon S, Xia X, Catanuto P, Rubio G, Shahzeidi S, El Salem F, Shapiro J, Briegel K, Korach KS, Glassberg MK. MicroRNA let-7 downregulates ligand-independent estrogen receptor-mediated male-predominant pulmonary fibrosis. American Journal of Respiratory and Critical Care Medicine. 2019;200:1246–1257. doi: 10.1164/rccm.201903-0508OC. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Gilles & Slack (2018).Gilles ME, Slack FJ. Let-7 microRNA as a potential therapeutic target with implications for immunotherapy. Expert Opinion on Therapeutic Targets. 2018;22:929–939. doi: 10.1080/14728222.2018.1535594. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Gopu et al. (2020).Gopu V, Fan L, Shetty RS, Nagaraja MR, Shetty S. Caveolin-1 scaffolding domain peptide regulates glucose metabolism in lung fibrosis. JCI Insight. 2020;5:e137969. doi: 10.1172/jci.insight.137969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Han et al. (2014).Han MK, Zhou Y, Murray S, Moore BB, White ES, Flaherty KR, Huffnagle GB, Martinez FJ. Lung microbiome and disease progression in idiopathic pulmonary fibrosis: an analysis of the COMET study. The Lancet Respiratory Medicine. 2014;2:548–556. doi: 10.1016/S2213-2600(14)70069-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Hromadnikova et al. (2017).Hromadnikova I, Kotlabova K, Ivankova K, Krofa L. First trimester screening of circulating microRNAs and the evaluation of their potential to predict the onset of preeclampsia and IUGR. PLOS ONE. 2017;12:e0171756. doi: 10.1371/journal.pone. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Hsu et al. (2017).Hsu HS, Liu CC, Lin JH, Hsu TW, Hsu JW, Su K, Hung SC. Involvement of ER stress, PI3K/AKT activation, and lung fibroblast proliferation in bleomycin-induced pulmonary fibrosis. Scientific Reports. 2017;7:14272. doi: 10.1038/s41598-017-14612-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Hu et al. (2020).Hu X, Xu Q, Wan H, Hu Y, Xing S, Yang H, Gao Y, He Z. PI3K-Akt-mTOR/PFKFB3 pathway mediated lung fibroblast aerobic glycolysis and collagen synthesis in lipopolysaccharide-induced pulmonary fibrosis. Laboratory Investigation. 2020;100:801–811. doi: 10.1038/s41374-020-0404-9. [DOI] [PubMed] [Google Scholar]
  • Huang et al. (2021).Huang F, Ren M, Pei J, Mei H, Sui B, Wu Q, Chai B, Yang R, Zhou M, Fu ZF, Zhou H, Zhao L. Preexposure and postexposure prophylaxis of rabies with adeno-associated virus expressing virus-neutralizing antibody in rodent models. Frontiers in Microbiology. 2021;12:702273. doi: 10.3389/fmicb.2021.702273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Huang et al. (2012).Huang Y, Dai Y, Zhang J, Wang C, Li D, Cheng J, Lu Y, Ma K, Tan L, Xue F, Qin B. Circulating microRNAs as potential biomarkers for smoking-related interstitial fibrosis. Biomarkers. 2012;17:435–440. doi: 10.3109/1354750X.2012.680611. [DOI] [PubMed] [Google Scholar]
  • Kang (2021).Kang H. Sample size determination and power analysis using the G*Power software. Journal of Educational Evaluation for Health Professions. 2021;18:17. doi: 10.3352/jeehp.2021.18.17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Knippenberg et al. (2015).Knippenberg S, Ueberberg B, Maus R, Bohling J, Ding N, Tort Tarres M, Hoymann HG, Jonigk D, Izykowski N, Paton JC, Ogunniyi AD, Lindig S, Bauer M, Welte T, Seeger W, Guenther A, Sisson TH, Gauldie J, Kolb M, Maus UA. Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin. Thorax. 2015;70:636–646. doi: 10.1136/thoraxjnl-2014-206420. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Kroh et al. (2010).Kroh EM, Parkin RK, Mitchell PS, Tewari M. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR) Methods. 2010;50:298–301. doi: 10.1016/j.ymeth.2010.01.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Laddha & Kulkarni (2019).Laddha AP, Kulkarni YA. VEGF and FGF-2: promising targets for the treatment of respiratory disorders. Respiratory Medicine. 2019;156:33–46. doi: 10.1016/j.rmed.2019.08.003. [DOI] [PubMed] [Google Scholar]
  • Li et al. (2018).Li D, Ji H, Zhao B, Xu C, Xia W, Han L, Yu D, Ju Y, Jin C. Therapeutic effect of ulinastatin on pulmonary fibrosis via downregulation of TGF-β1, TNF-α and NF-κB. Molecular Medicine Reports. 2018;17:1717–1723. doi: 10.3892/mmr.2017.8056. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Li (2009).Li JY. The role of COX-2 in acute lung injury. Chinese Journal of Emergency Medicine. 2009;18:1341–1342. [Google Scholar]
  • Lin, Chang & Ying (2006).Lin SL, Chang SJ, Ying SY. Transgene-like animal models using intronic microRNAs. Methods in Molecular Biology. 2006;342:321–334. doi: 10.1385/1-59745-123-1:321. [DOI] [PubMed] [Google Scholar]
  • Liu et al. (2012).Liu B, Zhang H, Hao M, Yu S. Establishment and characterization of two fetal fibroblast cell lines from the yak. Animal. 2012;48:619–624. doi: 10.1007/s11626-012-9559-z. [DOI] [PubMed] [Google Scholar]
  • Liu et al. (2021).Liu Y, Nie H, Ding Y, Hou Y, Mao K, Cui Y. MiRNA, a new treatment strategy for pulmonary fibrosis. Current Drug Targets. 2021;22:793–802. doi: 10.2174/1874609813666200928141822. [DOI] [PubMed] [Google Scholar]
  • Liu et al. (2018).Liu YY, Shi Y, Liu Y, Pan XH, Zhang KX. Telomere shortening activates TGF-β/Smads signaling in lungs and enhances both lipopolysaccharide and bleomycin-induced pulmonary fibrosis. Acta Pharmacologica Sinica. 2018;39:1735–1745. doi: 10.1038/s41401-018-0007-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Marenzoni et al. (2011).Marenzoni ML, Passamonti F, Lepri E, Cercone M, Capomaccio S, Cappelli K, Felicetti M, Coppola G, Coletti M, Thiry E. Quantification of Equid herpesvirus 5 DNA in clinical and necropsy specimens collected from a horse with equine multinodular pulmonary fibrosis. Journal of Veterinary Diagnostic Investigation. 2011;23:802–806. doi: 10.1177/1040638711407890. [DOI] [PubMed] [Google Scholar]
  • Margaria et al. (2022).Margaria JP, Moretta L, Alves-Filho JC, Hirsch E. PI3K signaling in mechanisms and treatments of pulmonary fibrosis following sepsis and acute lung injury. Biomedicines. 2022;10:756. doi: 10.3390/biomedicines10040756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Meng, Zhang & Zhang (2013).Meng Q, Zhang B, Zhang C. A new method of measuring the titrator of recombinant gland-related virus genomes. The Journal of Bioscience and Bioengineering. 2013;29:235–242. [Google Scholar]
  • Moore et al. (2000).Moore BB, Coffey MJ, Christensen P, Sitterding S, Ngan R, Wilke CA, McDonald R, Phare SM, Peters-Golden M, Paine 3rd R, Toews GB. GM-CSF regulates bleomycin-induced pulmonary fibrosis via a prostaglandin-dependent mechanism. Journal of Immunology. 2000;165:4032–4039. doi: 10.4049/jimmunol.165.7.4032. [DOI] [PubMed] [Google Scholar]
  • Seggev, Goren & Kirkpatrick (1984).Seggev JS, Goren MB, Kirkpatrick CH. The pathogenesis of trehalose dimycolate-induced interstitial pneumonitis. III. Evidence for a role for T lymphocytes. Cellular Immunology. 1984;85:428–435. doi: 10.1016/0008-8749(84)90256-9. [DOI] [PubMed] [Google Scholar]
  • Selvarajah et al. (2021).Selvarajah B, Azuelos I, Anastasiou D, Chambers RC. Fibrometabolism-An emerging therapeutic frontier in pulmonary fibrosis. Science Signaling. 2021;14:eaay1027. doi: 10.1126/scisignal.aay1027. [DOI] [PubMed] [Google Scholar]
  • Slota et al. (2019).Slota JA, Medina SJ, Klassen M, Gorski D, Mesa CM, Robertson C, Mitchell G, Coulthart MB, Pritzkow S, Soto C, Booth SA. Identification of circulating microRNA signatures as potential biomarkers in the serum of elk infected with chronic wasting disease. Scientific Reports. 2019;9:19705. doi: 10.1038/s41598-019-56249-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Sun et al. (2019a).Sun J, Zhao L, Wu H, Lian W, Cui C, Du Z, Luo W, Li M, Yang S. Analysis of miRNA-seq in the liver of common carp (Cyprinus carpio L.) in response to different environmental temperatures. Functional & Integrative Genomics. 2019a;19:265–280. doi: 10.1007/s10142-018-0643-7. [DOI] [PubMed] [Google Scholar]
  • Sun et al. (2019b).Sun L, Zhu M, Feng W, Lin Y, Yin J, Jin J, Wang Y. Exosomal miRNA Let-7 from menstrual blood-derived endometrial stem cells alleviates pulmonary fibrosis through regulating mitochondrial DNA damage. Oxidative Medicine and Cellular Longevity. 2019b;2019:4506303. doi: 10.1155/2019/4506303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Sun et al. (2018).Sun X, Dongol S, Qiu C, Xu Y, Sun C, Zhang Z, Yang X, Zhang Q, Kong B. miR-652 promotes tumor proliferation and metastasis by targeting RORA in endometrial cancer. Molecular Cancer Research. 2018;16:1927–1939. doi: 10.1158/1541-7786. [DOI] [PubMed] [Google Scholar]
  • Tian et al. (2019).Tian Y, Li H, Gao Y, Liu C, Qiu T, Wu H, Cao M, Zhang Y, Ding H, Chen J, Cai H. Quantitative proteomic characterization of lung tissue in idiopathic pulmonary fibrosis. Clinical Proteomics. 2019;16:6. doi: 10.1186/s12014-019-9226-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Wang et al. (2021a).Wang L, Li S, Yao Y, Yin W, Ye T. The role of natural products in the prevention and treatment of pulmonary fibrosis: a review. Food & Function. 2021a;12:990–1007. doi: 10.1039/d0fo03001e. [DOI] [PubMed] [Google Scholar]
  • Wang et al. (2017).Wang Q, Liu S, Zhao X, Wang Y, Tian D, Jiang W. MiR-372-3p promotes cell growth and metastasis by targeting FGF9 in lung squamous cell carcinoma. Cancer Medicine. 2017;6:1323–1330. doi: 10.1002/cam4.1026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Wang et al. (2021b).Wang S, Wei J, Shi J, He Q, Zhou X, Gao X, Cheng L. Follistatin-like 1 attenuation suppresses intervertebral disc degeneration in mice through interacting with TNF-α and smad signaling pathway. Oxidative Medicine and Cellular Longevity. 2021b;2021:6640751. doi: 10.1155/2021/6640751. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Williams (2014).Williams KJ. Gammaherpesviruses and pulmonary fibrosis: evidence from humans, horses, and rodents. Veterinary Pathology. 2014;51:372–384. doi: 10.1177/0300985814521838. [DOI] [PubMed] [Google Scholar]
  • Wu, Tang & Kapoor (2021).Wu B, Tang L, Kapoor M. Fibroblasts and their responses to chronic injury in pulmonary fibrosis. Seminars in Arthritis and Rheumatism. 2021;51:310–317. doi: 10.1016/j.semarthrit.2020.12.003. [DOI] [PubMed] [Google Scholar]
  • Wu et al. (2018b).Wu Q, Zhou Y, Feng FC, Jin YH, Wang ZC, Zhou XM. Probing into the mechanism of alkaline citrus extract promoted apoptosis in pulmonary fibroblasts of bleomycin-induced pulmonary fibrosis mice. Evidence-Based Complementary and Alternative Medicine. 2018b;2018:9658950. doi: 10.1155/2018/9658950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Xie et al. (2011).Xie T, Liang J, Guo R, Liu N, Noble PW, Jiang D. Comprehensive microRNA analysis in bleomycin-induced pulmonary fibrosis identifies multiple sites of molecular regulation. Physiological Genomics. 2011;43:479–487. doi: 10.1152/physiolgenomics.00222.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Yin et al. (2021).Yin EG, Liu YJ, Yang M, Dong ZX. Research progress of glucose metabolism and pulmonary fibrosis. Medical Recapitulate. 2021;27:2935–2939. [Google Scholar]
  • Zhang, Wang & Lin (1997).Zhang DY, Wang WG, Lin Y, Wang ZZ, Yang XM, Li L, Kang JP, Li QB. Isolation identification and prevention of epidemic pneumonia of musk deer. Chinese Journal of Veterinary Science. 1997;5:48–51. doi: 10.16303/j.cnki.1005-4545.1997.05.016. [DOI] [Google Scholar]
  • Zhao et al. (2021).Zhao W, Ren Z, Luo Y, Cheng J, Wang J, Wang Y, Yang Z, Yao X, Zhong Z, Yang W, Wu X. Metagenomics analysis of the gut microbiome in healthy and bacterial pneumonia forest musk deer. Genes Genomics. 2021;43:43–53. doi: 10.1007/s13258-020-01029-0. [DOI] [PubMed] [Google Scholar]
  • Zhao et al. (2017).Zhao W, Tian Q, Luo Y, Wang Y, Yang ZX, Yao XP, Cheng JG, Zhou X, Wang WY. Isolation, identification, and genome analysis of lung pathogenic Klebsiella pneumoniae (LPKP) in forest musk deer. Journal of Zoo and Wildlife Medicine. 2017;48:1039–1048. doi: 10.1638/2016-0241.1. [DOI] [PubMed] [Google Scholar]
  • Zhao et al. (2020).Zhao W, Yu D, Cheng J, Wang Y, Yang Z, Yao X, Luo Y. Identification and pathogenicity analysis of Streptococcus equinus FMD1, a beta-hemolytic strain isolated from forest musk deer lung. Journal of Veterinary Medical Science. 2020;82:172–176. doi: 10.1292/jvms.19-0566. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • Zhu et al. (2011).Zhu H, Shyh-Chang N, Segrè AV, Shinoda G, Shah SP, Einhorn WS, Takeuchi A, Engreitz JM, Hagan JP, Kharas MG, Urbach A, Thornton JE, Triboulet R, Gregory RI, Altshuler D, Daley GQ. DIAGRAM Consortium; MAGIC Investigators The Lin28/let-7 axis regulates glucose metabolism. Cell. 2011;147:81–94. doi: 10.1016/j.cell.2011.08.033. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Information 1. Supplemental Information.

Table S1: RT-qPCR primers used for the verification of miRNAs; Table S2: RT-qPCR primers used for the verification of mRNAs; Table S3: Information of PCR primers for recombinant double luciferase reporter plasmids; Table S4: Overview of small RNA sequencing data in this study; Figure S1: Package of the recombinant adeno-associated virus; Figure S2: Isolation and identification of pathogens in forest musk deer lung; Figure S3: Verification of recombinant luciferase reporter plasmid.

DOI: 10.7717/peerj.14097/supp-1
Data S1. Raw data.
DOI: 10.7717/peerj.14097/supp-2
Supplemental Information 3. Original_Images for Blots/Gels.
DOI: 10.7717/peerj.14097/supp-3
Supplemental Information 4. Author Check.
DOI: 10.7717/peerj.14097/supp-4
Supplemental Information 5. Explanation of miRNA-seq raw data.
DOI: 10.7717/peerj.14097/supp-5

Data Availability Statement

The following information was supplied regarding data availability:

The miRNA-sequencing raw data of forest musk deer is available at NCBI Sequence Read Archive: SRX9254510–SRX9254519.


Articles from PeerJ are provided here courtesy of PeerJ, Inc

RESOURCES